Last reviewed · How we verify
NCT04977414
Making Data Count Intervention Evaluation
NA trial testing Making Data Count Training intervention in Statistical Process Control Charts in 15 participants. Completed in 30 June 2023.
31 January 2023
Quick facts
| Lead sponsor | University of Warwick |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 15 |
| Start date | 1 October 2021 |
| Primary completion | 31 January 2023 |
| Estimated completion | 30 June 2023 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Making Data Count Training intervention
Conditions studied
- Statistical Process Control Charts — all drugs for Statistical Process Control Charts →
Sponsor
University of Warwick
Who can join
Eligibility, any sex, with Statistical Process Control Charts. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hospitals collect copious amounts of data to share with their board for quality assurance and improvement purposes. The way these data are presented can influence board members' decisions. For example, time-series charts highlight the highest and lowest data but do not clarify whether those data lie outside expected or 'common cause' variation. Statistical process control charts make this clarification and, in so doing, guide quality assurance and improvements in a more targeted fashion. A previous study showed that data suitable for presentation as a control chart are seldom presented in that format. A training intervention called 'Making Data Count' was created to improve the uptake of statistical process control charts by hospitals in England. The current study will use a randomized design to evaluate whether the intervention increases control charts in hospitals that were not early adopters of the training intervention. This study is a parallel cluster randomized trial (with baseline-line measurements) across 20 National Health Service (NHS) hospitals in England. The hospitals will be randomly split into two groups. One group will be scheduled to experience the training intervention, and the other group will be placed on a waiting list to experience the training later. The primary analysis will compare the difference in the use of control charts between waitlist and intervention hospitals (adjusting for pre-intervention use) reported with 95% confidence intervals. A qualitative thematic analysis of feedback forms will be conducted. The present research will evaluate the impact of the training intervention on the use of control charts. The results will apply to institutions that are not early adopters of this training intervention.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Cluster randomised evaluation of a training intervention to increase the use of statistical process control charts for hospitals in England: making data count.
Schmidtke KA, Kudrna L, Quinn L, Bird P, et al · · 2025 · cited 4× · PMID 39237263 · DOI 10.1136/bmjqs-2024-017094
Verify or expand the search:
- PubMed search for NCT04977414
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Warwick trials
Trials by the same sponsor.
- NCT06334718 — Drone Delivered Defibrillators (The 3D Project). · completed
- NCT05402436 — Breast Screening Atypia and Subsequent Development of Cancer in England · completed
- NCT05046197 — Evaluating the Integration of the Recommended Summary Plan for Emergency Care Treatment (ReSPECT) Into Primary Care · completed
- NCT05247463 — English Mammography Screening Outcomes by Age, Frequency and Test Threshold · unknown
- NCT04546854 — Influenza 2020/2021 · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04977414 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Warwick
- Last refreshed: 11 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04977414.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing